Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Observational × Fulvestrant × Clear all

Status

Sponsor Class

OTHER 10 INDUSTRY 8 UNKNOWN 1

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 1 palbociclib 1 niraparib 1 Therapeutics 1 Standard of Care 1 Radiotherapy, Adjuvant 1 Radiation 1 Pharmaceutical Preparations 1 Neoadjuvant Therapy 1 Methods 1 Immunotherapy 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04289974 2020-02-28

Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

ChineseAMS

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡